Market cap is higher because TLX is pulling $700m pa and is on track for a billion by years end.
Two more FIC products about to hit the market with conservatively $1.5b TAM between them.
A prostate therapy ph3 completed that has previously shown almost 4x overall survival of pluvicto next in line.
A tad more advanced hence the higher MC.
CU6 will do likewise eventually I'm almost certain.
Research/Valuation, page-407
-
- There are more pages in this discussion • 190 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.30 |
Change
0.270(4.48%) |
Mkt cap ! $1.986B | |||
| Open | High | Low | Value | Volume |
| $6.04 | $6.48 | $6.03 | $11.24M | 1.775M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 11110 | $6.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.30 | 33950 | 3 |
View Market Depth
| Last trade - 16.10pm 19/08/2024 (20 minute delay) ? |
| CU6 (ASX) Chart |